Expert insights. Personalized for you.
While agency advisers raised concerns over molnupiravir's modest benefits and potential risks, a majority felt the antiviral drug is a needed option for COVID-19 patients at high risk of severe disease MORE
SUMMARY: When it comes to reaching health care professionals, there is only one choice as far as I am concerned, and that’s Medscape. Working with them has always been a pleasure, and we can always “list match” targeted physicians. MORE
Final trial data for molnupiravir were less convincing than what Merck previously reported and could alter how the FDA views the drug, which will be evaluated at a meeting Tuesday MORE
After several family members had early heart attacks, Kathiresan vowed to understand why they happen. His research journey has changed medical practice and led to a new biotech startup, Verve Therapeutics, that seeks to prevent them MORE
Several companies, including Pfizer and Moderna, are already at work adapting their coronavirus shots to the newly identified variant, which experts worry could more readily evade vaccine protection MORE
The development of biological products (or biologics) represents a major advancement in modern medicine, enabling the treatment of patients with many illnesses where no other therapeutics were previously available. MORE
The biotech, which has been stung by recent clinical setbacks, plans to soon advance the medicine into late-stage testing MORE
A $250 million acquisition of startup Lengo Therapeutics has given Blueprint a lung cancer drug that could compete with medicines from Takeda and J&J MORE
Annual Drug Patent Expirations for FLOVENT+HFA Flovent Hfa is a drug marketed by Glaxo Grp Ltd and is included in one NDA. It is available from four suppliers. There are…. The post New patent expiration for Glaxo Grp drug FLOVENT HFA appeared first on DrugPatentWatch - Make Better Decisions. MORE
New York, NY—December 1, 2021— Extracting metals from oxides at high temperatures is essential not only for producing metals such as steel but also for recycling. MORE
SUMMARY: The U.S. needs to take substantial steps to address the high costs of cancer drugs. From 2009 to 2019, the median monthly treatment costs for new drugs at launch reached $11,755 in the U.S… … Does the question become how much is a month(s) of other life worth? MORE
An investigator-led trial of Jazz Pharma’s cannabis extract-based drug Sativex in glioblastoma – an aggressive form of brain cancer – will get underway in the UK next year. MORE
Ultra-processed foods are a major public health concern for their potential adverse effects on health. Now a study by the Department of Epidemiology and Prevention of the I.R.C.C.S. MORE
81 OPENING: TV is great at creating awareness, but it can also scare patients away if one of your side effects is “may lead to death.” MORE
130 
Out of an "abundance of caution," the companies halted enrollment in a trial evaluating the combination of Merck's islatravir and Gilead's lenacapavir MORE
The oil industry put fiber-optic sensing cables downhole to better understand why hydraulic fracturing doesn’t free trapped oil at expected rates in shale reservoirs, but the massive streams of information received are hard to analyze. MORE
Healthy living can lead to better living and improved overall quality of life. Who doesn’t want that? So, here are some tips to help you acquire a healthy lifestyle, beginning with nutrition and exercise which play a starring role in health management. Nutrition. MORE
52 
Organic-inorganic halide perovskite materials have excellent optical capture capacity and carrier conductivity. Perovskite solar cells, with amazing power conversion efficiency, show great application prospects. MORE
82 
Omicron has caused the U.S. to install travel bans against several South African countries while vaccine makers rush to test their vaccines against it. For that news and more, continue reading MORE
CPhI awards the first ever CPhI Verified certificate to Medinfar – an international pharmaceutical manufacturer of Rx, cosmetics, food supplements and veterinary products. MORE
Philip Dormitzer, who helped Pfizer develop shots for COVID-19, RSV and influenza, will become the British pharma's head of vaccine R&D next month MORE
52 
In October, Vertex Pharmaceuticals announced stunning results in a type 1 diabetes patient who had been dosed with the company’s experimental therapy MORE
97 
Sigilon Therapeutics announced it may have discovered the reason why its experimental cell therapy treatment for severe hemophilia A was placed on clinical hold by the FDA MORE
A new treatment using stem cells that produce insulin has surprised experts and given them hope for the 1.5 million Americans living with the disease. MORE
FS Development Corp. II Announces Effectiveness of Registration Statement for Proposed Business Combination with Pardes Special Meeting Scheduled for December 23, 2021 FS Development Corp. MORE
52 
[link] Credit: FSR [link] Special Issue: Sharing Clinical and Forensic Toxicology Knowledge in the Era of a Pandemic and Beyond This special issue includes an editorial, one review, five research articles and two case reports from leading scientists in the field that further the discussion on clinical and forensic toxicology. MORE
Moderna, BioNTech and Johnson & Johnson have all started developing Omicron-specific vaccines: among a wider response plan to the SARS-CoV-2 variant. Bio Developments MORE
A new variant of COVID-19 identified in Botswana with dozens of mutations is being watched closely, amid fears it could be resistant to the effect of currently-used vaccines. MORE
Rockville, Emmes today announced that it conducted the data and statistical analysis for the third iteration of the Adaptive COVID-19 Treatment Trial (ACTT-3), using its proprietary Advantage eClinical system. MORE
52 
A “Frankenstein mix” of mutations raises concerns, but the variant may remain vulnerable to current vaccines. If not, revisions will be necessary. MORE
Bio Pharma Dive
NOVEMBER 30, 2021
While agency advisers raised concerns over molnupiravir's modest benefits and potential risks, a majority felt the antiviral drug is a needed option for COVID-19 patients at high risk of severe disease
World of DTC Marketing
DECEMBER 1, 2021
OPENING: TV is great at creating awareness, but it can also scare patients away if one of your side effects is “may lead to death.”
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Bio Pharma Dive
NOVEMBER 26, 2021
Final trial data for molnupiravir were less convincing than what Merck previously reported and could alter how the FDA views the drug, which will be evaluated at a meeting Tuesday
World of DTC Marketing
NOVEMBER 24, 2021
SUMMARY: The U.S. needs to take substantial steps to address the high costs of cancer drugs. From 2009 to 2019, the median monthly treatment costs for new drugs at launch reached $11,755 in the U.S… … Does the question become how much is a month(s) of other life worth?
Speaker: Steve Goldstein, Sales Leader
Currently in sales or involved in a business that depends on strong sales results? Join Steve Goldstein, Sales Success Coach, Motivational Speaker and Medical Device Sales Leader from Gold Selling LLC. You will absorb critical strategies to become a trusted partner in greater sales success.
Camargo
NOVEMBER 29, 2021
The development of biological products (or biologics) represents a major advancement in modern medicine, enabling the treatment of patients with many illnesses where no other therapeutics were previously available.
Scienmag
DECEMBER 1, 2021
Credit: RSNA and Charlie Hamm, M.D.
Clinical Research Informer brings together the best content for pharmaceutical professionals from the widest variety of industry thought leaders.
|
Bio Pharma Dive
NOVEMBER 28, 2021
After several family members had early heart attacks, Kathiresan vowed to understand why they happen. His research journey has changed medical practice and led to a new biotech startup, Verve Therapeutics, that seeks to prevent them
World of DTC Marketing
NOVEMBER 29, 2021
SUMMARY: When it comes to reaching health care professionals, there is only one choice as far as I am concerned, and that’s Medscape. Working with them has always been a pleasure, and we can always “list match” targeted physicians.
Pharma Phorum
NOVEMBER 28, 2021
An investigator-led trial of Jazz Pharma’s cannabis extract-based drug Sativex in glioblastoma – an aggressive form of brain cancer – will get underway in the UK next year.
Scienmag
DECEMBER 1, 2021
New York, NY—December 1, 2021— Extracting metals from oxides at high temperatures is essential not only for producing metals such as steel but also for recycling.
Advertiser: Aggregage
The federal government is developing a rule requiring employers with more than 100 employees ensure their workers are vaccinated or produce a negative COVID test weekly before entering the workplace. So, what can your organization do to prepare? Get Paycor’s COVID Vaccination Policy Template to help communicate important details to your employees.
BioSpace
NOVEMBER 28, 2021
In October, Vertex Pharmaceuticals announced stunning results in a type 1 diabetes patient who had been dosed with the company’s experimental therapy
BioTech 365
DECEMBER 1, 2021
Scienmag
NOVEMBER 24, 2021
In sub-Saharan Africa, 7 million people with HIV live more than 10 minutes from health care services and 1.5
BioSpace
NOVEMBER 28, 2021
Omicron has caused the U.S. to install travel bans against several South African countries while vaccine makers rush to test their vaccines against it. For that news and more, continue reading
Bio Pharma Dive
NOVEMBER 24, 2021
Out of an "abundance of caution," the companies halted enrollment in a trial evaluating the combination of Merck's islatravir and Gilead's lenacapavir
Riverside Clinical Research
DECEMBER 1, 2021
Healthy living can lead to better living and improved overall quality of life. Who doesn’t want that? So, here are some tips to help you acquire a healthy lifestyle, beginning with nutrition and exercise which play a starring role in health management. Nutrition.
BioTech 365
DECEMBER 1, 2021
Scienmag
NOVEMBER 29, 2021
The oil industry put fiber-optic sensing cables downhole to better understand why hydraulic fracturing doesn’t free trapped oil at expected rates in shale reservoirs, but the massive streams of information received are hard to analyze.
Pharma Mirror
DECEMBER 1, 2021
Rockville, Emmes today announced that it conducted the data and statistical analysis for the third iteration of the Adaptive COVID-19 Treatment Trial (ACTT-3), using its proprietary Advantage eClinical system.
Bio Pharma Dive
DECEMBER 1, 2021
The biotech, which has been stung by recent clinical setbacks, plans to soon advance the medicine into late-stage testing
Pharma Phorum
NOVEMBER 25, 2021
A new variant of COVID-19 identified in Botswana with dozens of mutations is being watched closely, amid fears it could be resistant to the effect of currently-used vaccines.
BioTech 365
DECEMBER 1, 2021
FS Development Corp. II Announces Effectiveness of Registration Statement for Proposed Business Combination with Pardes Special Meeting Scheduled for December 23, 2021 FS Development Corp.
Scienmag
NOVEMBER 29, 2021
Organic-inorganic halide perovskite materials have excellent optical capture capacity and carrier conductivity. Perovskite solar cells, with amazing power conversion efficiency, show great application prospects.
Pharma Mirror
DECEMBER 1, 2021
CPhI awards the first ever CPhI Verified certificate to Medinfar – an international pharmaceutical manufacturer of Rx, cosmetics, food supplements and veterinary products.
Bio Pharma Dive
NOVEMBER 29, 2021
A $250 million acquisition of startup Lengo Therapeutics has given Blueprint a lung cancer drug that could compete with medicines from Takeda and J&J
Drug Patent Watch
NOVEMBER 30, 2021
Annual Drug Patent Expirations for FLOVENT+HFA Flovent Hfa is a drug marketed by Glaxo Grp Ltd and is included in one NDA. It is available from four suppliers. There are…. The post New patent expiration for Glaxo Grp drug FLOVENT HFA appeared first on DrugPatentWatch - Make Better Decisions.
BioTech 365
DECEMBER 1, 2021
Scienmag
NOVEMBER 29, 2021
Ultra-processed foods are a major public health concern for their potential adverse effects on health. Now a study by the Department of Epidemiology and Prevention of the I.R.C.C.S.
BioPharma Reporter
NOVEMBER 29, 2021
Moderna, BioNTech and Johnson & Johnson have all started developing Omicron-specific vaccines: among a wider response plan to the SARS-CoV-2 variant. Bio Developments
Bio Pharma Dive
NOVEMBER 29, 2021
Several companies, including Pfizer and Moderna, are already at work adapting their coronavirus shots to the newly identified variant, which experts worry could more readily evade vaccine protection
BioSpace
NOVEMBER 28, 2021
Sigilon Therapeutics announced it may have discovered the reason why its experimental cell therapy treatment for severe hemophilia A was placed on clinical hold by the FDA
Scienmag
NOVEMBER 29, 2021
[link] Credit: FSR [link] Special Issue: Sharing Clinical and Forensic Toxicology Knowledge in the Era of a Pandemic and Beyond This special issue includes an editorial, one review, five research articles and two case reports from leading scientists in the field that further the discussion on clinical and forensic toxicology.
NY Times
NOVEMBER 28, 2021
A “Frankenstein mix” of mutations raises concerns, but the variant may remain vulnerable to current vaccines. If not, revisions will be necessary.
Bio Pharma Dive
NOVEMBER 30, 2021
Philip Dormitzer, who helped Pfizer develop shots for COVID-19, RSV and influenza, will become the British pharma's head of vaccine R&D next month
Let's personalize your content